Julià Blanco

11.3k total citations
213 papers, 6.4k citations indexed

About

Julià Blanco is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Julià Blanco has authored 213 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Virology, 90 papers in Infectious Diseases and 79 papers in Immunology. Recurrent topics in Julià Blanco's work include HIV Research and Treatment (137 papers), Immune Cell Function and Interaction (58 papers) and HIV/AIDS drug development and treatment (45 papers). Julià Blanco is often cited by papers focused on HIV Research and Treatment (137 papers), Immune Cell Function and Interaction (58 papers) and HIV/AIDS drug development and treatment (45 papers). Julià Blanco collaborates with scholars based in Spain, France and United States. Julià Blanco's co-authors include Bonaventura Clotet, José A. Esté, Jorge Carrillo, Marta Massanella, Javier Martínez‐Picado, Nuria Izquierdo‐Useros, Jordi Barretina, Cecilia Cabrera, Rafael Franco and María C. Puertas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Julià Blanco

207 papers receiving 6.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Julià Blanco 2.9k 2.1k 2.1k 1.9k 1.0k 213 6.4k
Xavier Álvarez 1.8k 0.6× 2.7k 1.3× 2.7k 1.3× 1.4k 0.7× 1.6k 1.5× 137 7.6k
Jonathan B. Angel 1.7k 0.6× 1.9k 0.9× 1.8k 0.9× 708 0.4× 1.4k 1.3× 177 5.5k
Thomas N. Denny 1.4k 0.5× 1.2k 0.6× 1.5k 0.7× 1.1k 0.6× 916 0.9× 162 5.0k
Sunil K. Ahuja 1.9k 0.7× 1.4k 0.7× 3.2k 1.5× 1.0k 0.5× 1.1k 1.1× 117 6.8k
Petronela Ancuța 4.0k 1.4× 2.2k 1.0× 4.4k 2.1× 1.3k 0.7× 1.5k 1.5× 96 8.2k
Myra O. McClure 2.5k 0.9× 2.1k 1.0× 1.3k 0.6× 1.6k 0.9× 1.8k 1.8× 172 6.8k
Beth D. Jamieson 2.9k 1.0× 1.7k 0.8× 3.7k 1.8× 1.1k 0.6× 1.4k 1.4× 92 7.3k
Philip J. Norris 1.9k 0.7× 1.5k 0.7× 2.8k 1.3× 1.2k 0.6× 1.3k 1.2× 192 7.2k
Jay Rappaport 2.6k 0.9× 1.3k 0.6× 1.8k 0.9× 1.9k 1.0× 754 0.7× 144 5.6k
Thomas M. Folks 4.6k 1.6× 3.4k 1.6× 2.8k 1.3× 1.1k 0.6× 2.3k 2.2× 122 8.9k

Countries citing papers authored by Julià Blanco

Since Specialization
Citations

This map shows the geographic impact of Julià Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julià Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julià Blanco more than expected).

Fields of papers citing papers by Julià Blanco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julià Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julià Blanco. The network helps show where Julià Blanco may publish in the future.

Co-authorship network of co-authors of Julià Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of Julià Blanco. A scholar is included among the top collaborators of Julià Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julià Blanco. Julià Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alemany, Andrea, Edwards Pradenas, Ruth Aguilar, et al.. (2025). Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial. Frontiers in Immunology. 16. 1647488–1647488.
2.
Ramírez‐Morros, Anna, Marta Vidal, D. Herbert Opi, et al.. (2025). Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections. Journal of Infection. 90(4). 106473–106473. 8 indexed citations
3.
Ramírez‐Morros, Anna, Alfons Jiménez, Marta Vidal, et al.. (2025). Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection. Communications Medicine. 5(1). 243–243.
4.
5.
Tarrés-Freixas, Ferran, Eva Riveira‐Muñoz, Dàlia Raϊch‐Regué, et al.. (2025). A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model. mBio. 16(5). e0072025–e0072025. 3 indexed citations
6.
Roca-Ho, Heleia, Aïda Falgàs, Europa Azucena González‐Navarro, et al.. (2024). NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease. Journal for ImmunoTherapy of Cancer. 12(10). e009198–e009198. 2 indexed citations
7.
Ortiz, Raquel, Benjamin Trinité, Ferran Tarrés-Freixas, et al.. (2024). Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein. Viruses. 16(6). 987–987.
8.
Ávila‐Nieto, Carlos, et al.. (2023). Syphilis vaccine: challenges, controversies and opportunities. Frontiers in Immunology. 14. 1126170–1126170. 23 indexed citations
9.
Belda, F. J., Ana Vivanco, Sílvia Marfil, et al.. (2023). Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration. SHILAP Revista de lepidopterología. 17. 1 indexed citations
10.
Marfil, Sílvia, Edwards Pradenas, Rosa Valle, et al.. (2022). Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North‐Eastern Spain. Transboundary and Emerging Diseases. 69(6). 3518–3529. 9 indexed citations
11.
Muñoz‐Basagoiti, Jordana, Daniel Perez‐Zsolt, Rubén León, et al.. (2021). Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro. Journal of Dental Research. 100(11). 1265–1272. 54 indexed citations
12.
Díez, José María Soberanes, Carolina S. Romero, Maria Cristina Cruz, et al.. (2021). Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins. The Journal of Infectious Diseases. 225(6). 938–946. 22 indexed citations
13.
Rodon, Jordi, Edwards Pradenas, Sílvia Marfil, et al.. (2021). First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain. Viruses. 13(12). 2526–2526. 19 indexed citations
14.
Brustolin, Marco, Jordi Rodon, Maria Luisa Rodrı́guez de la Concepción, et al.. (2021). Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerging Microbes & Infections. 10(1). 797–809. 28 indexed citations
15.
Segalés, Joaquím, Jordi Rodon, Carlos Ávila‐Nieto, et al.. (2020). Detection of SARS-CoV-2 in a cat owned by a COVID-19−affected patient in Spain. Proceedings of the National Academy of Sciences. 117(40). 24790–24793. 124 indexed citations
16.
Berdasco, María, Anuska Llano, Beatriz Mothe, et al.. (2020). Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control. PLoS Pathogens. 16(8). e1008678–e1008678. 20 indexed citations
17.
Olvera, Àlex, Anuska Llano, Beatriz Mothe, et al.. (2020). TL1A–DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1–Specific T Cell Responses. The Journal of Immunology. 205(12). 3348–3357. 3 indexed citations
18.
Vamvaka, Evangelia, Gemma Farré, Abbey Evans, et al.. (2018). Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm. Proceedings of the National Academy of Sciences. 115(33). E7854–E7862. 28 indexed citations
19.
Casado, Concha, María Pernas, Sílvia Marfil, et al.. (2018). Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers. mBio. 9(2). 35 indexed citations
20.
García, Elisabet, Víctor Urrea, Marta Massanella, et al.. (2017). Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Scientific Reports. 7(1). 11711–11711. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Álvarez Breakdown of academic impact, for papers by Jonathan B. Angel Breakdown of academic impact, for papers by Thomas N. Denny Breakdown of academic impact, for papers by Sunil K. Ahuja Breakdown of academic impact, for papers by Petronela Ancuța Breakdown of academic impact, for papers by Myra O. McClure Breakdown of academic impact, for papers by Beth D. Jamieson Breakdown of academic impact, for papers by Philip J. Norris Breakdown of academic impact, for papers by Jay Rappaport Breakdown of academic impact, for papers by Thomas M. Folks
Rankless by CCL
2026